Quent Capital, LLC Apellis Pharmaceuticals, Inc. Call Options Transaction History
Quent Capital, LLC
- $882 Million
- Q2 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding APLS
# of Institutions
336Shares Held
111MCall Options Held
1.26MPut Options Held
1.14M-
Wellington Management Group LLP Boston, MA15.1MShares$595 Million0.16% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.4MShares$449 Million19.04% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$439 Million7.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.51MShares$376 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$217 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $4.34B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...